Kestra Medical Technologies (NASDAQ:KMTS) Trading Up 2.9% – Here’s Why

by · The Cerbat Gem

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS – Get Free Report)’s stock price shot up 2.9% on Tuesday . The company traded as high as $26.00 and last traded at $25.82. 10,201 shares were traded during mid-day trading, a decline of 96% from the average session volume of 271,970 shares. The stock had previously closed at $25.10.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Wall Street Zen cut shares of Kestra Medical Technologies from a “hold” rating to a “sell” rating in a research report on Sunday, September 28th. BTIG Research assumed coverage on Kestra Medical Technologies in a research report on Tuesday. They set a “buy” rating and a $32.00 price target on the stock. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Kestra Medical Technologies in a research note on Wednesday, October 8th. Six equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Kestra Medical Technologies presently has an average rating of “Moderate Buy” and an average price target of $28.00.

Read Our Latest Stock Analysis on KMTS

Kestra Medical Technologies Trading Up 4.9%

The stock’s fifty day moving average price is $24.66 and its 200 day moving average price is $20.45. The stock has a market cap of $1.36 billion and a P/E ratio of -10.33. The company has a current ratio of 6.84, a quick ratio of 6.84 and a debt-to-equity ratio of 0.23.

Kestra Medical Technologies (NASDAQ:KMTS – Get Free Report) last issued its quarterly earnings data on Thursday, September 11th. The company reported ($0.50) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.66) by $0.16. The company had revenue of $19.37 million for the quarter, compared to the consensus estimate of $17.68 million. Kestra Medical Technologies has set its FY 2026 guidance at EPS.

Institutional Investors Weigh In On Kestra Medical Technologies

Hedge funds and other institutional investors have recently made changes to their positions in the business. Millennium Management LLC lifted its stake in shares of Kestra Medical Technologies by 534.7% in the 3rd quarter. Millennium Management LLC now owns 219,706 shares of the company’s stock worth $5,220,000 after purchasing an additional 185,090 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Kestra Medical Technologies in the third quarter worth approximately $185,000. Bank of America Corp DE boosted its stake in shares of Kestra Medical Technologies by 161.2% during the 3rd quarter. Bank of America Corp DE now owns 21,591 shares of the company’s stock worth $513,000 after acquiring an additional 13,325 shares during the last quarter. Alliancebernstein L.P. grew its position in shares of Kestra Medical Technologies by 13.7% during the 3rd quarter. Alliancebernstein L.P. now owns 1,491,970 shares of the company’s stock valued at $35,449,000 after acquiring an additional 179,885 shares during the period. Finally, Longaeva Partners L.P. increased its stake in shares of Kestra Medical Technologies by 342.7% in the 3rd quarter. Longaeva Partners L.P. now owns 136,182 shares of the company’s stock worth $3,236,000 after purchasing an additional 105,421 shares in the last quarter.

Kestra Medical Technologies Company Profile

(Get Free Report)

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.

Further Reading